185 related articles for article (PubMed ID: 15772306)
1. The role of the 132-160 region in prion protein conformational transitions.
Torrent J; Alvarez-Martinez MT; Liautard JP; Balny C; Lange R
Protein Sci; 2005 Apr; 14(4):956-67. PubMed ID: 15772306
[TBL] [Abstract][Full Text] [Related]
2. Physical studies of conformational plasticity in a recombinant prion protein.
Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
[TBL] [Abstract][Full Text] [Related]
3. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
4. Slow conformational dynamics in the hamster prion protein.
Kuwata K; Kamatari YO; Akasaka K; James TL
Biochemistry; 2004 Apr; 43(15):4439-46. PubMed ID: 15078089
[TBL] [Abstract][Full Text] [Related]
5. Alternative prion structural changes revealed by high pressure.
Torrent J; Alvarez-Martinez MT; Heitz F; Liautard JP; Balny C; Lange R
Biochemistry; 2003 Feb; 42(5):1318-25. PubMed ID: 12564935
[TBL] [Abstract][Full Text] [Related]
6. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity.
Safar J; Roller PP; Gajdusek DC; Gibbs CJ
Protein Sci; 1993 Dec; 2(12):2206-16. PubMed ID: 7905316
[TBL] [Abstract][Full Text] [Related]
7. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
[TBL] [Abstract][Full Text] [Related]
8. Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: analysis by X-ray diffraction.
Inouye H; Kirschner DA
J Struct Biol; 1998; 122(1-2):247-55. PubMed ID: 9724626
[TBL] [Abstract][Full Text] [Related]
9. Structural dependence of the cellular isoform of prion protein on solvent: spectroscopic characterization of an intermediate conformation.
Pergami P; Bramanti E; Ascoli GA
Biochem Biophys Res Commun; 1999 Nov; 264(3):972-8. PubMed ID: 10544040
[TBL] [Abstract][Full Text] [Related]
10. Conformational changes and development of proteinase K resistance in surface-immobilized PrP.
Leclerc E; Vetter S
Arch Virol; 2008; 153(4):683-91. PubMed ID: 18278426
[TBL] [Abstract][Full Text] [Related]
11. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
Havsteen BH
J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
[TBL] [Abstract][Full Text] [Related]
12. RNA molecules stimulate prion protein conversion.
Deleault NR; Lucassen RW; Supattapone S
Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
[TBL] [Abstract][Full Text] [Related]
13. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups.
Lucassen R; Nishina K; Supattapone S
Biochemistry; 2003 Apr; 42(14):4127-35. PubMed ID: 12680767
[TBL] [Abstract][Full Text] [Related]
14. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry.
Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR
J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059
[TBL] [Abstract][Full Text] [Related]
15. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
16. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
[TBL] [Abstract][Full Text] [Related]
17. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein.
Mehlhorn I; Groth D; Stöckel J; Moffat B; Reilly D; Yansura D; Willett WS; Baldwin M; Fletterick R; Cohen FE; Vandlen R; Henner D; Prusiner SB
Biochemistry; 1996 Apr; 35(17):5528-37. PubMed ID: 8611544
[TBL] [Abstract][Full Text] [Related]
18. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
Bertho G; Bouvier G; Hoa GH; Girault JP
Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
[TBL] [Abstract][Full Text] [Related]
19. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy.
Kuroda Y; Maeda Y; Sawa S; Shibata K; Miyamoto K; Nakagawa T
J Pept Sci; 2003 Apr; 9(4):212-20. PubMed ID: 12725242
[TBL] [Abstract][Full Text] [Related]
20. The elusive intermediate on the folding pathway of the prion protein.
Jenkins DC; Sylvester ID; Pinheiro TJ
FEBS J; 2008 Mar; 275(6):1323-35. PubMed ID: 18279390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]